AI assistant
Sending…
Solid Biosciences Inc. — Director's Dealing 2021
Feb 16, 2021
33003_dirs_2021-02-16_903cf01a-1302-41ba-b826-d1fb1eb524fb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2021-02-12
Reporting Person: Ganot Ilan (Director, CEO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-12 | Common Stock | S | 457 | $7.6611 | Disposed | 3026 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 290914 | Indirect |
| Common Stock | 1199821 | Direct |
Footnotes
F1: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.
F2: Represents 290,914 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
F3: Represents 1,139,190 shares held by Mr. Ganot as an individual, and 60,631 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
More from Solid Biosciences Inc.
Interim / Quarterly Report
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Board/Management Information
2026
Apr 10
Capital/Financing Update
2026
Mar 19
Annual Report
2026
Mar 19
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19